Parkinson's Disease 3 Medical, surgical, and physical treatments for Parkinson's disease

被引:1
作者
Foltynie, Tom [1 ]
Bruno, Veronica [2 ]
Fox, Susan [3 ,4 ]
Kuehn, Andrea A. [5 ,6 ,7 ]
Lindop, Fiona [8 ]
Lees, Andrew J. [1 ,9 ]
机构
[1] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Dept Clin & Movement Neurosci, London WC1N 3BG, England
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[3] Toronto Western Hosp, Krembil Brain Inst, Edmond J Safra Program Parkinson Dis, Toronto, ON, Canada
[4] Univ Toronto, Div Neurol, Toronto, ON, Canada
[5] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany
[6] Charite Univ Med Berlin, NeuroCure Cluster Excellence, Berlin, Germany
[7] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[8] Univ Hosp Derby & Burton NHS Fdn Trust, Florence Nightingale Community Hosp, Specialist Rehabil, Derby, England
[9] UCL, Reta Lila Weston Inst Neurol Studies, London, England
关键词
DEEP-BRAIN-STIMULATION; SLEEP BEHAVIOR DISORDER; PLACEBO-CONTROLLED TRIAL; OXIDASE B INHIBITORS; DOUBLE-BLIND; SUBTHALAMIC NUCLEUS; MOTOR FLUCTUATIONS; OPEN-LABEL; SUBCUTANEOUS APOMORPHINE; SYMPTOMATIC TREATMENT;
D O I
10.1016/S0140-6736(23)01429-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although dopamine replacement therapy remains a core component of Parkinson's disease treatment, the onset of motor fluctuations and dyskinetic movements might require a range of medical and surgical approaches from a multidisciplinary team, and important new approaches in the delivery of dopamine replacement are becoming available. The more challenging, wide range of non-motor symptoms can also have a major impact on the quality of life of a patient with Parkinson's disease, and requires careful multidisciplinary management using evidence-based knowledge, as well as appropriately tailored strategies according to the individual patient's needs. Disease-modifying therapies are urgently needed to prevent the development of the most disabling refractory symptoms, including gait and balance difficulties, cognitive impairment and dementia, and speech and swallowing impairments. In the third paper in this Series, we present the latest evidence supporting the optimal treatment of Parkinson's disease, and describe an expert approach to many aspects of treatment choice where an evidence base is insufficient.
引用
收藏
页码:305 / 324
页数:20
相关论文
共 213 条
[31]   Novel Programming Features Help Alleviate Subthalamic Nucleus Stimulation-Induced Side Effects [J].
Dayal, Viswas ;
De Roquemaurel, Alexis ;
Grover, Timothy ;
Ferreira, Francisca ;
Salazar, Maricel ;
Milabo, Catherine ;
Candelario-McKeown, Joseph ;
Zrinzo, Ludvic ;
Akram, Harith ;
Limousin, Patricia ;
Foltynie, Thomas .
MOVEMENT DISORDERS, 2020, 35 (12) :2261-2269
[32]   The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A Post Hoc Exploratory Analysis of Phase 2/3 Clinical Trial [J].
de Almeida, Carlos Mauricio Oliveira ;
Brito, Manuelina Mariana Capellari ;
Bosaipo, Nayanne Beckmann ;
Pimentel, Angela Vieira ;
Sobreira-Neto, Manoel Alves ;
Tumas, Vitor ;
Zuardi, Antonio Waldo ;
Crippa, Jose Alexandre de Souza ;
Hallak, Jaime Eduardo Cecilio ;
Eckeli, Alan Luiz .
CANNABIS AND CANNABINOID RESEARCH, 2023, 8 (02) :374-378
[33]   Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study [J].
De Cock, Valerie Cochen ;
Dodet, Pauline ;
Leu-Semenescu, Smaranda ;
Aerts, Cecile ;
Castelnovo, Giovanni ;
Abril, Beatriz ;
Drapier, Sophie ;
Olivet, Helene ;
Corbille, Anne-Gaelle ;
Leclair-Visonneau, Laurene ;
Sallansonnet-Froment, Magali ;
Lebouteux, Marie ;
Anheim, Mathieu ;
Ruppert, Elisabeth ;
Vitello, Nicolas ;
Eusebio, Alexandre ;
Lambert, Isabelle ;
Marques, Ana ;
Fantini, Maria Livia ;
Devos, David ;
Monaca, Christelle ;
Benard-Serre, Nicolas ;
Lacombe, Sandy ;
Vidailhet, Marie ;
Arnulf, Isabelle ;
Doulazmi, Mohamed ;
Roze, Emmanuel .
LANCET NEUROLOGY, 2022, 21 (05) :428-437
[34]   A randomized trial of deep-brain stimulation for Parkinson's disease [J].
Deuschl, Guenther ;
Schade-Brittinger, Carmen ;
Krack, Paul ;
Volkmann, Jens ;
Schaefer, Helmut ;
Boetzel, Kai ;
Daniels, Christine ;
Deutschlaender, Angela ;
Dillmann, Ulrich ;
Eisner, Wilhelm ;
Gruber, Doreen ;
Hamel, Wolfgang ;
Herzog, Jan ;
Hilker, Ruediger ;
Klebe, Stephan ;
Kloss, Manja ;
Koy, Jan ;
Krause, Martin ;
Kupsch, Andreas ;
Lorenz, Delia ;
Lorenzl, Stefan ;
Mehdorn, H. Maximilian ;
Moringlane, Jean Richard ;
Oertel, Wolfgang ;
Pinsker, Marcus O. ;
Reichmann, Heinz ;
Reuss, Alexander ;
Schneider, Gerd-Helge ;
Schnitzler, Alfons ;
Steude, Ulrich ;
Sturm, Volker ;
Timmermann, Lars ;
Tronnier, Volker ;
Trottenberg, Thomas ;
Wojtecki, Lars ;
Wolf, Elisabeth ;
Poewe, Werner ;
Voges, Juergen .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :896-908
[35]   European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies [J].
Deuschl, Gunther ;
Antonini, Angelo ;
Costa, Joao ;
Smilowska, Katarzyna ;
Berg, Daniela ;
Corvol, Jean-Christophe ;
Fabbrini, Giovanni ;
Ferreira, Joaquim ;
Foltynie, Tom ;
Mir, Pablo ;
Schrag, Annette ;
Seppi, Klaus ;
Taba, Pille ;
Ruzicka, Evzen ;
Selikhova, Marianna ;
Henschke, Nicholas ;
Villanueva, Gemma ;
Moro, Elena .
MOVEMENT DISORDERS, 2022, 37 (07) :1360-1374
[36]   Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment [J].
Dobkin, Roseanne D. ;
Mann, Sarah L. ;
Weintraub, Daniel ;
Rodriguez, Kailyn M. ;
Miller, Rachael B. ;
St. Hill, Lauren ;
King, Arlene ;
Gara, Michael A. ;
Interian, Alejandro .
MOVEMENT DISORDERS, 2021, 36 (11) :2549-2558
[37]   Telephone-based cognitive behavioral therapy for depression in Parkinson disease A randomized controlled trial [J].
Dobkin, Roseanne D. ;
Mann, Sarah L. ;
Gara, Michael A. ;
Interian, Alejandro ;
Rodriguez, Kailyn M. ;
Menza, Matthew .
NEUROLOGY, 2020, 94 (16) :E1764-E1773
[38]   The European Physiotherapy Guideline for Parkinson's Disease: Implications for Neurologists [J].
Domingos, Josefa ;
Keus, Samyra H. J. ;
Dean, John ;
de Vries, Nienke M. ;
Ferreira, Joaquim J. ;
Bloem, Bastiaan R. .
JOURNAL OF PARKINSONS DISEASE, 2018, 8 (04) :499-502
[39]   Clozapine improves dyskinesias in Parkinson disease - A double-blind, placebo-controlled study [J].
Durif, F ;
Debilly, B ;
Galitzky, M ;
Morand, D ;
Viallet, F ;
Borg, M ;
Thobois, S ;
Broussolle, E ;
Rascol, O .
NEUROLOGY, 2004, 62 (03) :381-388
[40]   Botulinum toxin injections for adults with overactive bladder syndrome [J].
Duthie, James B. ;
Vincent, Michael ;
Herbison, G. Peter ;
Wilson, David Iain ;
Wilson, Don .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12)